nodes	percent_of_prediction	percent_of_DWPC	metapath
Trihexyphenidyl—Biperiden—CYP2D6—Parkinson's disease	0.00661	0.401	CrCbGaD
Trihexyphenidyl—Oxybutynin—CYP2D6—Parkinson's disease	0.00515	0.312	CrCbGaD
Trihexyphenidyl—Biperiden—ABCB1—Parkinson's disease	0.00472	0.286	CrCbGaD
Trihexyphenidyl—CHRM4—head—Parkinson's disease	0.00272	0.0637	CbGeAlD
Trihexyphenidyl—CHRM4—nervous system—Parkinson's disease	0.00258	0.0604	CbGeAlD
Trihexyphenidyl—CHRM2—forebrain—Parkinson's disease	0.00255	0.0597	CbGeAlD
Trihexyphenidyl—CHRM4—central nervous system—Parkinson's disease	0.00248	0.0582	CbGeAlD
Trihexyphenidyl—CHRM1—forebrain—Parkinson's disease	0.00232	0.0543	CbGeAlD
Trihexyphenidyl—CHRM2—cardiovascular system—Parkinson's disease	0.00215	0.0505	CbGeAlD
Trihexyphenidyl—CHRM5—head—Parkinson's disease	0.00212	0.0498	CbGeAlD
Trihexyphenidyl—CHRM3—forebrain—Parkinson's disease	0.00207	0.0486	CbGeAlD
Trihexyphenidyl—CHRM5—nervous system—Parkinson's disease	0.00201	0.0472	CbGeAlD
Trihexyphenidyl—CHRM4—brain—Parkinson's disease	0.00197	0.0462	CbGeAlD
Trihexyphenidyl—CHRM1—cardiovascular system—Parkinson's disease	0.00196	0.0459	CbGeAlD
Trihexyphenidyl—CHRM5—central nervous system—Parkinson's disease	0.00194	0.0455	CbGeAlD
Trihexyphenidyl—CHRM5—brain—Parkinson's disease	0.00154	0.0361	CbGeAlD
Trihexyphenidyl—CHRM2—head—Parkinson's disease	0.00146	0.0342	CbGeAlD
Trihexyphenidyl—CHRM2—nervous system—Parkinson's disease	0.00138	0.0324	CbGeAlD
Trihexyphenidyl—CHRM2—central nervous system—Parkinson's disease	0.00133	0.0312	CbGeAlD
Trihexyphenidyl—CHRM1—head—Parkinson's disease	0.00133	0.0311	CbGeAlD
Trihexyphenidyl—CHRM1—nervous system—Parkinson's disease	0.00126	0.0295	CbGeAlD
Trihexyphenidyl—CHRM1—central nervous system—Parkinson's disease	0.00121	0.0284	CbGeAlD
Trihexyphenidyl—CHRM3—head—Parkinson's disease	0.00119	0.0278	CbGeAlD
Trihexyphenidyl—CHRM3—nervous system—Parkinson's disease	0.00113	0.0264	CbGeAlD
Trihexyphenidyl—CHRM3—central nervous system—Parkinson's disease	0.00108	0.0254	CbGeAlD
Trihexyphenidyl—CHRM2—brain—Parkinson's disease	0.00106	0.0248	CbGeAlD
Trihexyphenidyl—CHRM1—brain—Parkinson's disease	0.000962	0.0225	CbGeAlD
Trihexyphenidyl—CHRM3—brain—Parkinson's disease	0.000861	0.0202	CbGeAlD
Trihexyphenidyl—CHRM5—GPCR downstream signaling—HTR7—Parkinson's disease	0.000509	0.000541	CbGpPWpGaD
Trihexyphenidyl—CHRM5—GPCR downstream signaling—DRD2—Parkinson's disease	0.000509	0.000541	CbGpPWpGaD
Trihexyphenidyl—CHRM1—GPCR ligand binding—EDN1—Parkinson's disease	0.000508	0.00054	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—PPP1R1B—Parkinson's disease	0.000508	0.00054	CbGpPWpGaD
Trihexyphenidyl—CHRM3—GPCR ligand binding—EDN1—Parkinson's disease	0.000507	0.000538	CbGpPWpGaD
Trihexyphenidyl—CHRM2—GPCR ligand binding—EDN1—Parkinson's disease	0.000502	0.000533	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling by GPCR—ADRBK1—Parkinson's disease	0.000499	0.00053	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—PDYN—Parkinson's disease	0.000492	0.000523	CbGpPWpGaD
Trihexyphenidyl—CHRM1—GPCR downstream signaling—ADORA2A—Parkinson's disease	0.000489	0.000519	CbGpPWpGaD
Trihexyphenidyl—CHRM3—GPCR downstream signaling—ADORA2A—Parkinson's disease	0.000487	0.000518	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling by GPCR—DRD2—Parkinson's disease	0.000483	0.000513	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling by GPCR—HTR7—Parkinson's disease	0.000483	0.000513	CbGpPWpGaD
Trihexyphenidyl—CHRM2—GPCR downstream signaling—ADORA2A—Parkinson's disease	0.000482	0.000513	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling by GPCR—ADRBK1—Parkinson's disease	0.000478	0.000508	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—PDYN—Parkinson's disease	0.000471	0.000501	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling by GPCR—HTR7—Parkinson's disease	0.000463	0.000492	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling by GPCR—DRD2—Parkinson's disease	0.000463	0.000492	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—GFAP—Parkinson's disease	0.000462	0.000492	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—GRM5—Parkinson's disease	0.000457	0.000486	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Circadian rythm related genes—MAPK8—Parkinson's disease	0.000452	0.000481	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—RIT2—Parkinson's disease	0.00045	0.000478	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—RIT2—Parkinson's disease	0.000448	0.000477	CbGpPWpGaD
Trihexyphenidyl—CHRM1—GPCR ligand binding—HTR2A—Parkinson's disease	0.000445	0.000473	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—RIT2—Parkinson's disease	0.000444	0.000472	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling by GPCR—ADORA2A—Parkinson's disease	0.000444	0.000472	CbGpPWpGaD
Trihexyphenidyl—CHRM3—GPCR ligand binding—HTR2A—Parkinson's disease	0.000443	0.000471	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—GFAP—Parkinson's disease	0.000443	0.000471	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling by GPCR—ADORA2A—Parkinson's disease	0.000442	0.00047	CbGpPWpGaD
Trihexyphenidyl—CHRM2—GPCR ligand binding—HTR2A—Parkinson's disease	0.000439	0.000466	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling by GPCR—ADORA2A—Parkinson's disease	0.000438	0.000466	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—GRM5—Parkinson's disease	0.000438	0.000465	CbGpPWpGaD
Trihexyphenidyl—CHRM2—SIDS Susceptibility Pathways—TNF—Parkinson's disease	0.000433	0.00046	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—GRK5—Parkinson's disease	0.000426	0.000453	CbGpPWpGaD
Trihexyphenidyl—CHRM4—GPCR downstream signaling—EDN1—Parkinson's disease	0.000426	0.000453	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—GRK5—Parkinson's disease	0.000425	0.000452	CbGpPWpGaD
Trihexyphenidyl—CHRM1—GPCR downstream signaling—HTR1A—Parkinson's disease	0.000424	0.000451	CbGpPWpGaD
Trihexyphenidyl—CHRM3—GPCR downstream signaling—HTR1A—Parkinson's disease	0.000423	0.000449	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—GRK5—Parkinson's disease	0.000421	0.000447	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Metabolism—DDC—Parkinson's disease	0.000419	0.000445	CbGpPWpGaD
Trihexyphenidyl—CHRM2—GPCR downstream signaling—HTR1A—Parkinson's disease	0.000419	0.000445	CbGpPWpGaD
Trihexyphenidyl—CHRM1—GPCR downstream signaling—TAC1—Parkinson's disease	0.000418	0.000444	CbGpPWpGaD
Trihexyphenidyl—CHRM3—GPCR downstream signaling—TAC1—Parkinson's disease	0.000416	0.000442	CbGpPWpGaD
Trihexyphenidyl—CHRM2—GPCR downstream signaling—TAC1—Parkinson's disease	0.000412	0.000438	CbGpPWpGaD
Trihexyphenidyl—CHRM1—GPCR downstream signaling—DRD1—Parkinson's disease	0.00041	0.000435	CbGpPWpGaD
Trihexyphenidyl—CHRM3—GPCR downstream signaling—DRD1—Parkinson's disease	0.000408	0.000434	CbGpPWpGaD
Trihexyphenidyl—CHRM5—GPCR downstream signaling—EDN1—Parkinson's disease	0.000408	0.000434	CbGpPWpGaD
Trihexyphenidyl—CHRM2—GPCR downstream signaling—DRD1—Parkinson's disease	0.000404	0.00043	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—FGF20—Parkinson's disease	0.000401	0.000426	CbGpPWpGaD
Trihexyphenidyl—CHRM1—GPCR downstream signaling—DRD3—Parkinson's disease	0.000397	0.000422	CbGpPWpGaD
Trihexyphenidyl—CHRM3—GPCR downstream signaling—DRD3—Parkinson's disease	0.000395	0.00042	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Metabolism—GSTA4—Parkinson's disease	0.000395	0.00042	CbGpPWpGaD
Trihexyphenidyl—CHRM2—GPCR downstream signaling—DRD3—Parkinson's disease	0.000392	0.000416	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—ADORA2A—Parkinson's disease	0.000389	0.000413	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Parkinson's disease	0.000389	0.000413	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling by GPCR—EDN1—Parkinson's disease	0.000387	0.000411	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling by GPCR—HTR1A—Parkinson's disease	0.000385	0.000409	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—FGF20—Parkinson's disease	0.000384	0.000408	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling by GPCR—HTR1A—Parkinson's disease	0.000384	0.000408	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—GRM4—Parkinson's disease	0.000383	0.000407	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—GRM4—Parkinson's disease	0.000381	0.000405	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling by GPCR—HTR1A—Parkinson's disease	0.00038	0.000404	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling by GPCR—TAC1—Parkinson's disease	0.000379	0.000403	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling by GPCR—TAC1—Parkinson's disease	0.000378	0.000402	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—GRM4—Parkinson's disease	0.000378	0.000401	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling by GPCR—TAC1—Parkinson's disease	0.000374	0.000398	CbGpPWpGaD
Trihexyphenidyl—CHRM4—GPCR downstream signaling—HTR2A—Parkinson's disease	0.000373	0.000396	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—ADORA2A—Parkinson's disease	0.000372	0.000396	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling by GPCR—DRD1—Parkinson's disease	0.000372	0.000395	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling by GPCR—DRD1—Parkinson's disease	0.000371	0.000394	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling by GPCR—EDN1—Parkinson's disease	0.00037	0.000394	CbGpPWpGaD
Trihexyphenidyl—CHRM1—GPCR downstream signaling—ADRBK1—Parkinson's disease	0.00037	0.000394	CbGpPWpGaD
Trihexyphenidyl—CHRM3—GPCR downstream signaling—ADRBK1—Parkinson's disease	0.000369	0.000392	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling by GPCR—DRD1—Parkinson's disease	0.000367	0.00039	CbGpPWpGaD
Trihexyphenidyl—CHRM2—GPCR downstream signaling—ADRBK1—Parkinson's disease	0.000366	0.000389	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—PENK—Parkinson's disease	0.000363	0.000385	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—MAG—Parkinson's disease	0.000363	0.000385	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—PENK—Parkinson's disease	0.000361	0.000384	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—MAG—Parkinson's disease	0.000361	0.000384	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling by GPCR—DRD3—Parkinson's disease	0.00036	0.000383	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling by GPCR—DRD3—Parkinson's disease	0.000359	0.000382	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—INSR—Parkinson's disease	0.000359	0.000381	CbGpPWpGaD
Trihexyphenidyl—CHRM1—GPCR downstream signaling—HTR7—Parkinson's disease	0.000359	0.000381	CbGpPWpGaD
Trihexyphenidyl—CHRM1—GPCR downstream signaling—DRD2—Parkinson's disease	0.000359	0.000381	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—PENK—Parkinson's disease	0.000358	0.00038	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—MAG—Parkinson's disease	0.000358	0.00038	CbGpPWpGaD
Trihexyphenidyl—CHRM3—GPCR downstream signaling—HTR7—Parkinson's disease	0.000358	0.00038	CbGpPWpGaD
Trihexyphenidyl—CHRM3—GPCR downstream signaling—DRD2—Parkinson's disease	0.000358	0.00038	CbGpPWpGaD
Trihexyphenidyl—CHRM5—GPCR downstream signaling—HTR2A—Parkinson's disease	0.000357	0.000379	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Metabolism—PLA2G6—Parkinson's disease	0.000356	0.000378	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling by GPCR—DRD3—Parkinson's disease	0.000356	0.000378	CbGpPWpGaD
Trihexyphenidyl—CHRM2—GPCR downstream signaling—DRD2—Parkinson's disease	0.000354	0.000376	CbGpPWpGaD
Trihexyphenidyl—CHRM2—GPCR downstream signaling—HTR7—Parkinson's disease	0.000354	0.000376	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Metabolism—MAOB—Parkinson's disease	0.000352	0.000375	CbGpPWpGaD
Trihexyphenidyl—CHRM2—SIDS Susceptibility Pathways—IL6—Parkinson's disease	0.000349	0.000371	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—INSR—Parkinson's disease	0.000344	0.000365	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—FGB—Parkinson's disease	0.000339	0.00036	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling by GPCR—HTR2A—Parkinson's disease	0.000338	0.00036	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—HTR1A—Parkinson's disease	0.000337	0.000359	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling by GPCR—ADRBK1—Parkinson's disease	0.000336	0.000357	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling by GPCR—ADRBK1—Parkinson's disease	0.000335	0.000356	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—TAC1—Parkinson's disease	0.000332	0.000353	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling by GPCR—ADRBK1—Parkinson's disease	0.000332	0.000353	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—PDYN—Parkinson's disease	0.000332	0.000353	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—PDYN—Parkinson's disease	0.000331	0.000351	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—PDYN—Parkinson's disease	0.000327	0.000348	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—DRD1—Parkinson's disease	0.000326	0.000346	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling by GPCR—DRD2—Parkinson's disease	0.000326	0.000346	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling by GPCR—HTR7—Parkinson's disease	0.000326	0.000346	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—FGB—Parkinson's disease	0.000325	0.000345	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling by GPCR—HTR7—Parkinson's disease	0.000325	0.000345	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling by GPCR—DRD2—Parkinson's disease	0.000325	0.000345	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling by GPCR—HTR2A—Parkinson's disease	0.000324	0.000344	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—HTR1A—Parkinson's disease	0.000323	0.000343	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling by GPCR—DRD2—Parkinson's disease	0.000322	0.000342	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling by GPCR—HTR7—Parkinson's disease	0.000322	0.000342	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—TAC1—Parkinson's disease	0.000318	0.000338	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—DRD3—Parkinson's disease	0.000316	0.000335	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—DRD1—Parkinson's disease	0.000312	0.000332	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—GFAP—Parkinson's disease	0.000312	0.000331	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—GFAP—Parkinson's disease	0.000311	0.00033	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—GRM5—Parkinson's disease	0.000308	0.000328	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—GFAP—Parkinson's disease	0.000308	0.000327	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—GRM5—Parkinson's disease	0.000307	0.000327	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—GRM5—Parkinson's disease	0.000304	0.000324	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—DRD3—Parkinson's disease	0.000302	0.000321	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—ADRBK1—Parkinson's disease	0.000295	0.000313	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Circadian rythm related genes—IL6—Parkinson's disease	0.000289	0.000307	CbGpPWpGaD
Trihexyphenidyl—CHRM1—GPCR downstream signaling—EDN1—Parkinson's disease	0.000287	0.000305	CbGpPWpGaD
Trihexyphenidyl—CHRM3—GPCR downstream signaling—EDN1—Parkinson's disease	0.000286	0.000304	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—HTR7—Parkinson's disease	0.000285	0.000303	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—DRD2—Parkinson's disease	0.000285	0.000303	CbGpPWpGaD
Trihexyphenidyl—CHRM2—GPCR downstream signaling—EDN1—Parkinson's disease	0.000283	0.000301	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—ADRBK1—Parkinson's disease	0.000282	0.0003	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Parkinson's disease	0.000274	0.000291	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—DRD2—Parkinson's disease	0.000273	0.00029	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—HTR7—Parkinson's disease	0.000273	0.00029	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Parkinson's disease	0.000273	0.00029	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—FGF20—Parkinson's disease	0.00027	0.000287	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—FGF20—Parkinson's disease	0.00027	0.000286	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—FGF20—Parkinson's disease	0.000267	0.000284	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—ADORA2A—Parkinson's disease	0.000262	0.000279	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Metabolism—CYP2D6—Parkinson's disease	0.000262	0.000278	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—ADORA2A—Parkinson's disease	0.000261	0.000278	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling by GPCR—EDN1—Parkinson's disease	0.000261	0.000277	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling by GPCR—EDN1—Parkinson's disease	0.00026	0.000276	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—ADORA2A—Parkinson's disease	0.000259	0.000275	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling by GPCR—EDN1—Parkinson's disease	0.000257	0.000274	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Metabolism—CTGF—Parkinson's disease	0.000257	0.000273	CbGpPWpGaD
Trihexyphenidyl—CHRM1—GPCR downstream signaling—HTR2A—Parkinson's disease	0.000251	0.000267	CbGpPWpGaD
Trihexyphenidyl—CHRM3—GPCR downstream signaling—HTR2A—Parkinson's disease	0.00025	0.000266	CbGpPWpGaD
Trihexyphenidyl—CHRM2—GPCR downstream signaling—HTR2A—Parkinson's disease	0.000248	0.000264	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—INSR—Parkinson's disease	0.000242	0.000257	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—INSR—Parkinson's disease	0.000241	0.000256	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Metabolism—CYP2E1—Parkinson's disease	0.00024	0.000255	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—IGF2—Parkinson's disease	0.000239	0.000254	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—INSR—Parkinson's disease	0.000239	0.000254	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Metabolism—NQO1—Parkinson's disease	0.000237	0.000252	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Metabolism—TH—Parkinson's disease	0.000233	0.000248	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—IGF1R—Parkinson's disease	0.000231	0.000246	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—IGF2—Parkinson's disease	0.000229	0.000243	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—FGB—Parkinson's disease	0.000229	0.000243	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—EDN1—Parkinson's disease	0.000228	0.000243	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling by GPCR—HTR2A—Parkinson's disease	0.000228	0.000242	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—FGB—Parkinson's disease	0.000228	0.000242	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—HTR1A—Parkinson's disease	0.000227	0.000242	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling by GPCR—HTR2A—Parkinson's disease	0.000227	0.000242	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—HTR1A—Parkinson's disease	0.000227	0.000241	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—FGB—Parkinson's disease	0.000226	0.00024	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling by GPCR—HTR2A—Parkinson's disease	0.000225	0.000239	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—HTR1A—Parkinson's disease	0.000225	0.000239	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Metabolism—CYCS—Parkinson's disease	0.000224	0.000238	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—TAC1—Parkinson's disease	0.000224	0.000238	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—TAC1—Parkinson's disease	0.000223	0.000237	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—IGF1R—Parkinson's disease	0.000221	0.000235	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—TAC1—Parkinson's disease	0.000221	0.000235	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—DRD1—Parkinson's disease	0.00022	0.000234	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—DRD1—Parkinson's disease	0.000219	0.000233	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—EDN1—Parkinson's disease	0.000219	0.000233	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—DRD1—Parkinson's disease	0.000217	0.000231	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—DRD3—Parkinson's disease	0.000213	0.000226	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—DRD3—Parkinson's disease	0.000212	0.000225	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—DRD3—Parkinson's disease	0.00021	0.000223	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—NGF—Parkinson's disease	0.00021	0.000223	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—NGF—Parkinson's disease	0.000201	0.000214	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—HTR2A—Parkinson's disease	0.0002	0.000212	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—ADRBK1—Parkinson's disease	0.000199	0.000211	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Metabolism—COMT—Parkinson's disease	0.000198	0.000211	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—ADRBK1—Parkinson's disease	0.000198	0.000211	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Metabolism—GSTP1—Parkinson's disease	0.000198	0.00021	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Metabolism—MAOA—Parkinson's disease	0.000197	0.000209	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—ADRBK1—Parkinson's disease	0.000196	0.000208	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Metabolism—HMOX1—Parkinson's disease	0.000195	0.000207	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—HTR7—Parkinson's disease	0.000192	0.000205	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—DRD2—Parkinson's disease	0.000192	0.000205	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—DRD2—Parkinson's disease	0.000192	0.000204	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—HTR7—Parkinson's disease	0.000192	0.000204	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—HTR2A—Parkinson's disease	0.000191	0.000203	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—HTR7—Parkinson's disease	0.00019	0.000202	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—DRD2—Parkinson's disease	0.00019	0.000202	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Metabolism—ABCB1—Parkinson's disease	0.000187	0.000199	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—APOE—Parkinson's disease	0.000186	0.000198	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Metabolism—GSTM1—Parkinson's disease	0.000182	0.000193	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—APOE—Parkinson's disease	0.000178	0.000189	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Metabolism—GPX1—Parkinson's disease	0.000174	0.000185	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—IGF2—Parkinson's disease	0.000161	0.000171	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—IGF2—Parkinson's disease	0.000161	0.000171	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Metabolism—MTHFR—Parkinson's disease	0.00016	0.000171	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—IGF2—Parkinson's disease	0.000159	0.000169	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—INS—Parkinson's disease	0.000159	0.000169	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—IGF1R—Parkinson's disease	0.000156	0.000166	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—IGF1R—Parkinson's disease	0.000155	0.000165	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—EDN1—Parkinson's disease	0.000154	0.000164	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—IGF1R—Parkinson's disease	0.000154	0.000164	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—EDN1—Parkinson's disease	0.000154	0.000163	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—EDN1—Parkinson's disease	0.000152	0.000162	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—INS—Parkinson's disease	0.000152	0.000162	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Metabolism—APOE—Parkinson's disease	0.000149	0.000159	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—NGF—Parkinson's disease	0.000142	0.00015	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—NGF—Parkinson's disease	0.000141	0.00015	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—NGF—Parkinson's disease	0.00014	0.000149	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—HTR2A—Parkinson's disease	0.000135	0.000143	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—HTR2A—Parkinson's disease	0.000134	0.000143	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—HTR2A—Parkinson's disease	0.000133	0.000141	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Metabolism—INS—Parkinson's disease	0.000128	0.000136	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—APOE—Parkinson's disease	0.000125	0.000133	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—APOE—Parkinson's disease	0.000125	0.000133	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—APOE—Parkinson's disease	0.000124	0.000131	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—CASP3—Parkinson's disease	0.000118	0.000126	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling by GPCR—IL6—Parkinson's disease	0.000117	0.000125	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—CASP3—Parkinson's disease	0.000113	0.00012	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling by GPCR—IL6—Parkinson's disease	0.000112	0.00012	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—MAPK8—Parkinson's disease	0.000109	0.000115	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—INS—Parkinson's disease	0.000107	0.000114	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—INS—Parkinson's disease	0.000107	0.000113	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—INS—Parkinson's disease	0.000106	0.000112	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—MAPK8—Parkinson's disease	0.000104	0.000111	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—CASP3—Parkinson's disease	7.97e-05	8.47e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—CASP3—Parkinson's disease	7.94e-05	8.44e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling by GPCR—IL6—Parkinson's disease	7.92e-05	8.42e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling by GPCR—IL6—Parkinson's disease	7.89e-05	8.39e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—CASP3—Parkinson's disease	7.87e-05	8.36e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling by GPCR—IL6—Parkinson's disease	7.82e-05	8.31e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—MAPK8—Parkinson's disease	7.32e-05	7.78e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—MAPK8—Parkinson's disease	7.3e-05	7.76e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—MAPK8—Parkinson's disease	7.23e-05	7.68e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—IL6—Parkinson's disease	6.94e-05	7.37e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—IL6—Parkinson's disease	6.64e-05	7.06e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—IL6—Parkinson's disease	4.68e-05	4.97e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—IL6—Parkinson's disease	4.66e-05	4.96e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—IL6—Parkinson's disease	4.62e-05	4.91e-05	CbGpPWpGaD
